Sign in
Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis
Journal article   Peer reviewed

Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis

Carlos Singer, Spiridon Papapetropaulos, D Ram Ayyar and Ashok Verma
Movement disorders, Vol.22(2), pp.289-289
2007-01-15
PMID: 17094101

Abstract

Botulinum Toxins, Type A - therapeutic use Torticollis - complications Humans Torticollis - drug therapy Female Aged Neuromuscular Agents - therapeutic use Amyotrophic Lateral Sclerosis - complications

Metrics

11 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.247 Migraines & Headaches
1.247.1001 Dystonia
Web Of Science research areas
Clinical Neurology
ESI research areas
Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details